Anti-Human Enolase 1/ENO1 Reference Antibody (HuL001, RUO) (HY081016)

Name: Anti-Human Enolase 1/ENO1 Reference Antibody (HuL001, RUO)
Brand: abinScience
SKU: HY081016
Price: 370 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HY081016
Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG
Clone ID	HuL001
Biological activity	HuL001 inhibits cancer-associated fibroblast-mediated tumor progression in a bortezomib ()-resistant multiple myeloma xenograft model [2].
Expression system	Mammalian cells
Clonality	Monoclonal
Target	Non-neural enolase, 2-phospho-D-glycerate hydro-lyase, MPB-1, ENO1, Plasminogen-binding protein, Enolase 1, C-myc promoter-binding protein, Alpha-enolase, MBP-1, MBPB1, MPB1, ENO1L1, NNE, Phosphopyruvate hydratase
Endotoxin level	< 10 EU/mg
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	P06733
Form	Liquid
Storage buffer	0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	HuL001
Background	Alpha-enolase (ENO1) is a ~47 kDa protein. Enolase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis and the reverse reaction in gluconeogenesis. Also involved in various processes such as growth control, hypoxia tolerance and allergic responses. May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons. Stimulates immunoglobulin production. 1. Sugahara, T. et al. (1992) Cytotechnology 10, 137-46. PMID: 1369209 2. Huang, H. et al. (2018) Molecular cell 70, 663-678.e6. PMID: 29775581 3. Feo, S. et al. (2000) FEBS letters 473, 47-52. PMID: 10802057 4. López-Alemany, R. et al. (2003) American journal of hematology 72, 234-42. PMID: 12666133 5. Ray, R. et al. (1991) Molecular and cellular biology 11, 2154-61. PMID: 2005901
References	1. Chao, K.S.C. et al. Tilting Immunometabolic Balance of Tumor Microenvironment by Targeting ENO1 in KRAS-Mutated Colorectal and Pancreatic Cancers. International Journal of Radiation Oncology, Biology, Physics, Volume 120, Issue 2, S97 [HY081016] 2. Maisie Huang, et al. Abstract LB067: Extracellular enolase-1 drives cancer-associated fibroblast differentiation in the tumor microenvironment to enhance tumor growth of multiple myeloma: Development of the therapeutic antibody, HuL001. Cancer Res 15 April 2025; 85 (8_Supplement_2): LB067. [HY081016]
Note	For research use only. Not suitable for clinical or therapeutic use.